Game-Changing Updates in the Management of Sickle Cell Disease
Needs Statement
Physicians and advanced practice providers in family medicine, internal medicine, pediatrics, and other medical specialties need to receive regular updates on clinical best practices. Newly published, clinically relevant, evidence-based, peer-reviewed research articles will be used as an impetus for discussion. The series aims is to accelerate the practice of evidence-based medicine across the physician enterprise to expand clinical knowledge, enhance the quality of care, and improve patient outcomes. The series also aims to disseminate disease-specific clinical best practices and to encourage networking and collaboration within and across medical specialties.
Target Audience
Physicians, fellows, residents, and other healthcare providers.
Learning Objectives
At the conclusion of the session, the participants should be able to:
- Identify and discuss historical management of sickle cell disease and present the current state of treatment.
- Integrate strategies and best practices for implementing new therapies.
- Discuss the social and ethical issues that arise when weighing the cost and current availability of treatment against the proven benefit of treatment.
- Recognize the importance of reviewing and discussing new clinical evidence in the context of improving care delivery and patient outcomes.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Baylor College of Medicine and CommonSpirit Health. Baylor College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Baylor College of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Ethics
- 1.00 Participation